Last 7 days
1.3%
Last 30 days
-4.0%
Last 90 days
18.2%
Trailing 12 Months
6.0%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HCA | 72.9B | 60.9B | -8.06% | 22.94% | 12.72 | 1.2 | 1.94% | -15.77% |
LH | 20.7B | 14.8B | -6.52% | -17.34% | 16.22 | 1.39 | -6.96% | -52.35% |
DGX | 14.9B | 9.6B | -3.55% | -6.97% | 18.73 | 1.55 | -10.08% | -57.84% |
MID-CAP | ||||||||
UHS | 9.9B | 13.6B | -12.63% | 5.29% | 14.64 | 0.74 | 5.04% | -26.87% |
DVA | 8.5B | 11.7B | 2.28% | -5.48% | 16.53 | 0.73 | 0.42% | -43.11% |
THC | 7.2B | 19.4B | -4.01% | 6.04% | 7.08 | 0.37 | 0.01% | -33.70% |
EHC | 6.1B | 4.4B | -4.71% | 18.34% | 22.47 | 1.4 | 8.15% | -30.89% |
SGRY | 4.6B | 2.6B | -8.02% | -9.34% | -50.32 | 1.77 | 13.01% | -143.24% |
SEM | 3.5B | 6.4B | -10.39% | 11.72% | 19.24 | 0.54 | 2.26% | -46.98% |
SMALL-CAP | ||||||||
RDNT | 1.7B | 1.5B | 4.59% | 39.15% | -126.11 | 1.14 | 10.24% | -173.11% |
ADUS | 1.4B | 976.1M | 8.11% | 5.42% | 28.51 | 1.47 | 10.19% | 12.37% |
BKD | 645.6M | 2.9B | -20.05% | -40.55% | -3.53 | 0.22 | 7.97% | -101.02% |
CYH | 437.6M | 12.2B | -49.53% | -39.62% | -109.4 | 0.04 | -2.06% | -101.36% |
SSY | 6.7M | 46.8M | -8.63% | -12.62% | -2.44 | 0.14 | 12.07% | -154.21% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 1.4% | 19,450 | 19,174 | 19,040 | 19,133 | 19,449 |
EBITDA | -6.0% | 3,075 | 3,272 | 3,671 | 3,743 | - |
EBITDA Margin | -6.7% | 0.16* | 0.17* | 0.19* | 0.19* | - |
Earnings Before Taxes | 0.1% | 1,346 | 1,344 | 1,551 | 1,945 | 1,999 |
EBT Margin | -14.0% | 0.07* | 0.08* | 0.10* | 0.10* | - |
Interest Expenses | -0.7% | 884 | 890 | 892 | 897 | 910 |
Net Income | 1.6% | 1,017 | 1,001 | 1,146 | 1,456 | 1,534 |
Net Income Margin | -13.3% | 0.05* | 0.06* | 0.08* | 0.08* | - |
Free Cahsflow | 32.1% | 321 | 243 | 414 | 570 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | -0.3% | 27,067 | 27,156 | 27,076 | 26,621 | 26,650 |
Current Assets | -1.9% | 5,869 | 5,981 | 5,998 | 6,064 | 6,128 |
Cash Equivalents | -10.7% | 766 | 858 | 1,208 | 1,351 | 1,405 |
Inventory | 0.5% | 407 | 405 | 394 | 387 | 391 |
Goodwill | 1.3% | 10,258 | 10,123 | 9,979 | 9,479 | 84.00 |
Liabilities | -1.3% | 22,262 | 22,548 | 22,501 | 22,510 | 22,236 |
Current Liabilities | -5.7% | 4,219 | 4,476 | 4,276 | 4,368 | 4,668 |
Long Term Debt | 0.0% | 14,935 | 14,934 | 14,962 | 14,947 | 14,719 |
Shareholder's Equity | 8.0% | 1,233 | 1,142 | 1,235 | 2,114 | 2,056 |
Retained Earnings | 17.8% | -660 | -803 | -905 | -1,036 | -1,074 |
Additional Paid-In Capital | -0.1% | 4,774 | 4,778 | 4,771 | 4,756 | 4,765 |
Shares Outstanding | -5.2% | 102 | 108 | 108 | 107 | - |
Minority Interest | 2.3% | 1,347 | 1,317 | 1,272 | 1,027 | 1,000 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | 20.4% | 1,304 | 1,083 | 1,019 | 1,136 | 1,262 |
Share Based Compensation | -3.6% | 54.00 | 56.00 | 60.00 | 60.00 | 58.00 |
Cashflow From Investing | -28.0% | -1,034 | -808 | -2,018 | -719 | -629 |
Cashflow From Financing | 49.0% | -909 | -1,781 | -85.00 | -1,260 | -1,369 |
Buy Backs | -20.0% | 200 | 250 | 0.00 | - | - |
87.3%
71.2%
66.2%
Y-axis is the maximum loss one would have experienced if Tenet Healthcare was unfortunately bought at previous high price.
4.0%
13.5%
14.7%
47.9%
FIve years rolling returns for Tenet Healthcare.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-26 | ProShare Advisors LLC | reduced | -22.48 | -22,622 | 382,189 | -% |
2023-05-23 | Brookfield Corp /ON/ | new | - | 1,776,540 | 1,776,540 | 0.01% |
2023-05-22 | AMERIPRISE FINANCIAL INC | added | 15.09 | 6,013,660 | 20,979,700 | 0.01% |
2023-05-22 | PUTNAM INVESTMENTS LLC | unchanged | - | 1,854,120 | 10,364,200 | 0.02% |
2023-05-18 | JPMORGAN CHASE & CO | reduced | -5.26 | 2,131,070 | 15,987,100 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | added | 123 | 10,274,000 | 16,229,000 | 0.02% |
2023-05-17 | Advisory Services Network, LLC | unchanged | - | 8,738 | 48,843 | -% |
2023-05-17 | Thrivent Financial for Lutherans | reduced | -0.92 | 290,000 | 1,695,000 | -% |
2023-05-17 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 8.24 | 31,314 | 1,346,600 | 0.01% |
2023-05-17 | B. Riley Wealth Advisors, Inc. | reduced | -12.51 | 20,817 | 338,635 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Mar 08, 2023 | blackrock inc. | 11.2% | 11,498,067 | SC 13G/A | |
Feb 14, 2023 | harris associates l p | 5.1% | 5,463,374 | SC 13G/A | |
Feb 14, 2023 | glenview capital management, llc | 8.23% | 8,896,111 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.45% | 11,304,003 | SC 13G/A | |
Feb 08, 2023 | invesco ltd. | 3.9% | 4,176,487 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 9.4% | 10,147,574 | SC 13G | |
Feb 14, 2022 | glenview capital management, llc | 6.84% | 7,327,108 | SC 13G/A | |
Feb 14, 2022 | invesco ltd. | 5.2% | 5,553,758 | SC 13G | |
Feb 11, 2022 | harris associates l p | 5.6% | 6,000,495 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 10.13% | 10,855,165 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
May 30, 2023 | 3 | Insider Trading | |
May 30, 2023 | 8-K | Current Report | |
May 30, 2023 | 4 | Insider Trading | |
May 30, 2023 | 4 | Insider Trading | |
May 30, 2023 | 4 | Insider Trading | |
May 30, 2023 | 4 | Insider Trading | |
May 30, 2023 | 4 | Insider Trading | |
May 30, 2023 | 4 | Insider Trading | |
May 30, 2023 | 4 | Insider Trading | |
May 30, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-05-19 | Arnst Thomas W | sold | -1,548,600 | 73.1231 | -21,178 | evp, chief admin. officer & gc |
2023-03-07 | Arnst Thomas W | sold | -96,112 | 60.07 | -1,600 | evp, chief admin. officer & gc |
2023-03-06 | Cancelmi Daniel J | acquired | - | - | 101,791 | evp & chief financial officer |
2023-03-06 | Arnst Thomas W | sold (taxes) | -656,354 | 58.9452 | -11,135 | evp, chief admin. officer & gc |
2023-03-06 | Ramsey R. Scott | sold (taxes) | -185,445 | 59.3995 | -3,122 | principal accounting officer |
2023-03-06 | Arnst Thomas W | sold | -50,325 | 61.00 | -825 | evp, chief admin. officer & gc |
2023-03-06 | Foo Lisa Y | acquired | - | - | 13,629 | evp, commercial ops |
2023-03-06 | Arnst Thomas W | acquired | - | - | 34,738 | evp, chief admin. officer & gc |
2023-03-06 | Foo Lisa Y | sold (taxes) | -275,162 | 59.4945 | -4,625 | evp, commercial ops |
2023-03-06 | Arbour Paola M | sold (taxes) | -698,116 | 59.3838 | -11,756 | evp, chief information officer |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Net operating revenues | $ 5,021 | $ 4,745 |
Grant income | 3 | 6 |
Equity in earnings of unconsolidated affiliates | 50 | 46 |
Operating expenses: | ||
Salaries, wages and benefits | 2,258 | 2,182 |
Supplies | 891 | 785 |
Other operating expenses, net | 1,093 | 942 |
Depreciation and amortization | 217 | 203 |
Impairment and restructuring charges, and acquisition-related costs | 21 | 16 |
Litigation and investigation costs | 4 | 20 |
Net losses (gains) on sales, consolidation and deconsolidation of facilities | (13) | 1 |
Operating income | 603 | 648 |
Interest expense | (221) | (227) |
Other non-operating expense, net | (2) | 0 |
Loss from early extinguishment of debt | 0 | (43) |
Income from continuing operations, before income taxes | 380 | 378 |
Income tax expense | (84) | (99) |
Income from continuing operations, before discontinued operations | 296 | 279 |
Discontinued operations: | ||
Income from operations | 0 | 1 |
Income from discontinued operations | 0 | 1 |
Net income | 296 | 280 |
Less: Net income available to noncontrolling interests | 153 | 140 |
Net income available to Tenet Healthcare Corporation common shareholders | 143 | 140 |
Amounts available to Tenet Healthcare Corporation common shareholders | ||
Income from continuing operations, net of tax | 143 | 139 |
Income from discontinued operations, net of tax | 0 | 1 |
Net income available to Tenet Healthcare Corporation common shareholders | $ 143 | $ 140 |
Basic | ||
Continuing operations (in dollars per share) | $ 1.40 | $ 1.29 |
Discontinued operations (in dollars per share) | 0 | 0.01 |
Total earnings (loss) per share, basic (in dollars per share) | 1.40 | 1.30 |
Diluted | ||
Continuing operations (in dollars per share) | 1.32 | 1.27 |
Discontinued operations (in dollars per share) | 0 | 0.01 |
Total earnings (loss) per share, diluted (in dollars per share) | $ 1.32 | $ 1.28 |
Weighted average shares and dilutive securities outstanding (in thousands): | ||
Basic (in shares) | 102,289 | 107,483 |
Diluted (in shares) | 106,006 | 112,020 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 766 | $ 858 |
Accounts receivable | 2,883 | 2,943 |
Inventories of supplies, at cost | 407 | 405 |
Assets held for sale | 142 | 0 |
Other current assets | 1,671 | 1,775 |
Total current assets | 5,869 | 5,981 |
Investments and other assets | 3,175 | 3,147 |
Deferred income taxes | 14 | 19 |
Property and equipment, at cost, less accumulated depreciation and amortization ($6,225 at March 31, 2023 and $6,201 at December 31, 2022) | 6,319 | 6,462 |
Goodwill | 10,258 | 10,123 |
Other intangible assets, at cost, less accumulated amortization ($1,429 at March 31, 2023 and $1,428 at December 31, 2022) | 1,432 | 1,424 |
Total assets | 27,067 | 27,156 |
Current liabilities: | ||
Current portion of long-term debt | 148 | 145 |
Accounts payable | 1,192 | 1,504 |
Accrued compensation and benefits | 602 | 778 |
Professional and general liability reserves | 256 | 255 |
Accrued interest payable | 248 | 213 |
Liabilities held for sale | 23 | 0 |
Contract liabilities | 76 | 110 |
Other current liabilities | 1,674 | 1,471 |
Total current liabilities | 4,219 | 4,476 |
Long-term debt, net of current portion | 14,935 | 14,934 |
Professional and general liability reserves | 810 | 790 |
Defined benefit plan obligations | 330 | 331 |
Deferred income taxes | 220 | 217 |
Other long-term liabilities | 1,748 | 1,800 |
Total liabilities | 22,262 | 22,548 |
Commitments and contingencies | ||
Redeemable noncontrolling interests in equity of consolidated subsidiaries | 2,225 | 2,149 |
Shareholders’ equity: | ||
Common stock, $0.05 par value; authorized 262,500,000 shares; 157,032,313 shares issued at March 31, 2023 and 156,462,456 shares issued at December 31, 2022 | 8 | 8 |
Additional paid-in capital | 4,774 | 4,778 |
Accumulated other comprehensive loss | (179) | (181) |
Accumulated deficit | (660) | (803) |
Common stock in treasury, at cost, 55,120,211 shares at March 31, 2023 and 54,215,871 shares at December 31, 2022 | (2,710) | (2,660) |
Total shareholders’ equity | 1,233 | 1,142 |
Noncontrolling interests | 1,347 | 1,317 |
Total equity | 2,580 | 2,459 |
Total liabilities and equity | $ 27,067 | $ 27,156 |